Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas

被引:0
作者
Mikami, T [1 ]
Saegusa, M [1 ]
Mitomi, H [1 ]
Yanagisawa, N [1 ]
Ichinoe, M [1 ]
Okayasu, I [1 ]
机构
[1] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa 2288555, Japan
关键词
extrahepatic bile duct; carcinoma; E-cadherin; alpha-catenin; beta-catenin; CD44;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas, 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays. Levels of E-cadherin, alpha-catenin, and beta-catenin proteins were lower in carcinomas than in normal mucosa, while CD44 variants 3 and 6 were upregulated. Well-differentiated carcinoma showed higher expression of E-cadherin and alpha-catenin than moderately to poorly differentiated types. Macroscopically, papillary lesions had higher expression of E-cadherin than their nonpapillary counterparts. RT-PCR/SBH for CD44 revealed the CD44 variant form to be more prevalent in carcinoma than in normal mucosa, correlating with the immunohistochemical results, and with more exon variety. The Cox proportional hazards test identified histologic type and E-cadherin expression as prognostic factors. Among the examined molecules, E-cadherin was especially related to papillary mass formation anti a good prognosis.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 37 条
  • [1] Albores-Saavedra J, 2000, CANCER, V89, P508, DOI 10.1002/1097-0142(20000801)89:3<508::AID-CNCR5>3.0.CO
  • [2] 2-D
  • [3] ALBORESSAAVEDRA J, 1991, WHO INT HISTOLOGICAL
  • [4] Altered expression of E-cadherin in breast cancer:: patterns, mechanisms and clinical significance
    Asgeirsson, KS
    Jónasson, JG
    Tryggvadóttir, L
    Olafsdóttir, K
    Sigurgeirsdóttir, JR
    Ingvarsson, S
    Ögmundsdóttir, HM
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (09) : 1098 - 1106
  • [5] Expression of E-cadherin, α-catenin, β-catenin, and CD44 (Standard and variant isoforms) in human cholangiocarcinoma:: An immunohistochemical study
    Ashida, K
    Terada, T
    Kitamura, Y
    Kaibara, N
    [J]. HEPATOLOGY, 1998, 27 (04) : 974 - 982
  • [6] Tumors of the gallbladder and bile ducts
    Baillie, J
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1999, 29 (01) : 14 - 21
  • [7] Chung C, 1998, AM SURGEON, V64, P921
  • [8] Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: Relationships with tumor grade, clinicopathologic parameters, and patients' survival
    Endo, K
    Ueda, T
    Ueyama, J
    Ohta, T
    Terada, T
    [J]. HUMAN PATHOLOGY, 2000, 31 (05) : 558 - 565
  • [9] Immunohistological analysis of E-cadherin, α-, β- and γ-catenin expression in colorectal cancer:: Implications for cell adhesion and signaling
    Ghadimi, BM
    Behrens, J
    Hoffmann, I
    Haensch, W
    Birchmeier, W
    Schlag, PM
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (01) : 60 - 65
  • [10] HENSON DE, 1992, CANCER, V70, P1498, DOI 10.1002/1097-0142(19920915)70:6<1498::AID-CNCR2820700609>3.0.CO